Rachel Brummert is a Special Government Employee (SGE) at the U.S. Food and Drug Administration (FDA) and is a Contributor for Drug Watch and Medshadow Foundation.
Following adverse reactions from a dose of Levaquin, she began advocating on behalf of patients who are harmed by pharmaceutical drugs and medical devices.
She founded Patient Safety Impact in 2017, and RSB Consulting in 2018.
Rachel resides in Charlotte, North Carolina with her husband and two dogs. In her spare time, she is a semi professional coffee drinker, an author, and amateur astronomer.
About Patient Safety Impact
Patient Safety Impact works in partnership with established consumer advocacy groups and agencies whose work centers around patient safety. Its focus is on healthcare, patient engagement, patient safety, and navigating through a flawed medical system.
About RSB Consulting
Headquartered in Charlotte, North Carolina, RSB Consulting provides expert advice in the areas of healthcare, medication and medical device safety, patient safety training, and mental health.